(Q36689014)

15 August 2017

1 reference

title

Postlicensure epidemiology of childhood vaccination: the Danish experience (English)

1 reference

15 August 2017

1 reference

Anders Hviid

1

0 references

language of work or name

1 reference

1 October 2006

1 reference

Expert Review of Vaccines

15 August 2017

published in

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

641-649

1 reference

Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Safety considerations for new vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Design and interpretation of vaccine field studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Keeping pace with the elusive Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Pertussis: persistent pathogen, imperfect vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Pertussis of adults and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Trends in pertussis among infants in the United States, 1980-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

A population-based study of measles, mumps, and rubella vaccination and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Neurologic disorders after measles-mumps-rubella vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

MMR vaccination and pervasive developmental disorders: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Retraction of an interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

The toxicology of mercury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

An assessment of the impact of thimerosal on childhood neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Association between thimerosal-containing vaccine and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Fever following immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

The timing of immunization affects the development of diabetes in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Childhood vaccination and type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Childhood vaccination and nontargeted infectious disease hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

The impact of pre-school booster vaccination of 4–6-year-old children on pertussis in 0–1-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

MMR Vaccination and Febrile Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.641

21 January 2018

Identifiers

DOI

10.1586/14760584.5.5.641

1 reference

15 August 2017

1 reference